Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
Norton
Alice
A
Fisher
Chris
C
Liu
Hui
H
Wen
Qiang
Q
Mundschau
Gina
G
Fuster
Jose Luis
JL
Hasle
Henrik
H
Zeller
Bernward
B
Webb
David K
DK
O'Marcaigh
Aengus
A
Sorrell
April
A
Hilden
Joanne
J
Gamis
Alan
A
Crispino
John D
JD
Vyas
Paresh
P
D002648:Child; D002675:Child, Preschool; D004314:Down Syndrome / Q000150:complications / Q000235:genetics*; D044127:Epigenesis, Genetic; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D053616:Janus Kinase 3 / Q000235:genetics*; D007951:Leukemia, Myeloid / Q000209:etiology / Q000235:genetics*; D008297:Male; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000209:etiology / Q000235:genetics*; D053628:Receptors, Thrombopoietin / Q000235:genetics*
D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; C507924:JAK2 protein, human; C507933:JAK3 protein, human; D053614:Janus Kinase 2; D053616:Janus Kinase 3